Release Date: 21/05/10 08:58 Summary: Revision of Full Year Guidance Price Sensitive: Yes Download Document 185.77KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%